Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein

2013 ◽  
Vol 22 (1) ◽  
pp. 269-277 ◽  
Author(s):  
Lidija Kitanovski ◽  
Janez Jazbec ◽  
Sergej Hojker ◽  
Metka Derganc
Keyword(s):  
Febrile Neutropenia ◽  
Diagnostic Accuracy ◽  
Interleukin 6 ◽  
Binding Protein ◽  
C Reactive Protein ◽  
Lipopolysaccharide Binding Protein ◽  
Clinical Sepsis ◽  
Reactive Protein ◽  
Lipopolysaccharide Binding

Value of lipopolysaccharide binding protein as diagnostic marker of infection in adult cancer patients with febrile neutropenia: comparison with C-reactive protein, procalcitonin, and interleukin 6

2015 ◽  
Vol 23 (7) ◽  
pp. 2175-2182 ◽  
Author(s):  
Luis García de Guadiana-Romualdo ◽  
Ignacio Español-Morales ◽  
Pablo Cerezuela-Fuentes ◽  
Luciano Consuegra-Sánchez ◽  
Ana Hernando-Holgado ◽  
...  
Keyword(s):  
Febrile Neutropenia ◽  
Cancer Patients ◽  
Interleukin 6 ◽  
Diagnostic Marker ◽  
Binding Protein ◽  
C Reactive Protein ◽  
Lipopolysaccharide Binding Protein ◽  
Reactive Protein ◽  
Lipopolysaccharide Binding

scholarly journals The Use of Selective Hemosorption of Lipopolysaccharides in the Complex Treatment of Sepsis

2020 ◽  
Vol 9 (2) ◽  
pp. 201-209
Author(s):  
G. V. Bulava ◽  
S. I. Rey ◽  
G. A. Berdnikov ◽  
O. V. Nikitina ◽  
A. K. Shabanov ◽  
...  
Keyword(s):  
Interleukin 6 ◽  
Binding Protein ◽  
Polymyxin B ◽  
Interleukin 10 ◽  
C Reactive Protein ◽  
Lipopolysaccharide Binding Protein ◽  
Reactive Protein ◽  
Endotoxin Activity ◽  
Blood Cytokines ◽  
Lipopolysaccharide Binding

Background Sepsis and septic shock are formidable and complications in surgery with mortality 20–50%. In the pathogenesis of sepsis, a significant role belongs to bacterial endotoxin (LPS - liposaccharide).Aim of study Assessment of the efficacy of selective lipopolysaccharides hemosorption (SLH) in treatment of sepsis.Material and methods We examined 65 patients with developed sepsis or suspected presence of gram-negative infection. Patients were retrospectively divided into two groups. In Group 1, 27 patients received Polymyxin B hemoperfusion using Toraymyxin cartridges. In Group 2 (38 patients), adsorber Alteco (LPSA) was used.Results It was established that 28-day mortality was 11.1% in Polymyxin group and 28.9% in LPS group A, p = 0.091, 60-day mortality was 33.3 and 55.3%, respectively (p=0.065). The use of SLH contributed to a decrease in the activity of endotoxin (EAA) from 0.52 (0.39; 0.65) to 0.40 (0.36; 0.57) EU (p=0.330) in Polymyxin group and from 0.59 ( 0.42; 0.72) to 0.54 (0.40; 0.81) EU ( p = 0.981) in the LPS-A group. At the same time, the level of procalcitonin (PCT) in the blood statistically significantly decreased from 8.4 (3.6; 29.0) to 4.8 (1.9; 36.3) ng/ml (p=0.0117) only in the LPS-A group. The level of C-reactive protein (CRB) in the blood statistically significantly decreased only in the Polymyxin group, from 205 (154; 264) to 162 (106; 202) mg/L (p<0.001). After SPH procedures, there was a tendency to a decrease in the level of blood cytokines in both groups. Conclusion 1. The trend of better survival among patients was noted during hemoperfusion when using Polymyxin B in comparison with the results of adsorption of lipopolysaccharide with Alteco cartridges: so, 28-day mortality was 11.1 and 28.9%, respectively (statistically not significant).2. As a result, the procedure of selective lipopolysaccharides hemosorbtion on hemosorbents with Polymyxin B in blood significantly decreased level of C-reactive protein (21%), there was statistically insignificant decrease in the level of endotoxin activity (23.1%), lipopolysaccharide binding protein (21.6%), procalcitonin (2.4 times), presepsin (20%), as well as the level of interleukin-6 (3.4 times) and interleukin-10 (1.6 times) . Adsorption of lipopolysaccharide with Alteco cartridges leads to a statistically significant reduction of procalcitonin in blood (1.8 times), and statistically insignificant decrease of: endotoxin activity (9.3%), lipopolysaccharide binding protein (28.6%), interleukin-6 (3.8 times), interleukin-10 (7.1 times) and soluble receptor to interleukin-2 (2.2 times).

scholarly journals Lipopolysaccharide-Binding Protein for Monitoring of Postoperative Sepsis: Complemental to C-Reactive Protein or Redundant?

PLoS ONE ◽  
2011 ◽  
Vol 6 (8) ◽  
pp. e23615 ◽  
Author(s):  
Klaus Tschaikowsky ◽  
Monika Hedwig-Geissing ◽  
Joachim Schmidt ◽  
Giovanni G. Braun
Keyword(s):  
Binding Protein ◽  
Postoperative Sepsis ◽  
C Reactive Protein ◽  
Lipopolysaccharide Binding Protein ◽  
Reactive Protein ◽  
Lipopolysaccharide Binding
Sign in / Sign up

Export Citation Format

Share Document